References
- Bonney A, Malouf R, Marchal C, et al. Impact of low‑dose computed tomography (LDCT) screening on lung cancer‑related mortality. Cochrane Database Syst Rev. 2022;8(8):CD013829. DOI: 10.1002/14651858.CD013829.pub2.
- Belgian Cancer Registry. Cancer fact sheet 2022 lung cancer [Internet]. 2024 [cited 2024 September 19]. Available from:
https://kankerregister.org/sites/default/files/2024/Cancer_Fact_Sheet_Lung%20Cancer_2022.pdf . - National Lung Screening Trial Research Team; Aberle DR, Adams AM, Berg CD, Black WC et al. Reduced lung‑cancer mortality with low‑dose computed tomographic screening. N Engl J Med. 2011 Aug 4;365(5):395–409. 10.1056/NEJMoa1102873.
- de Koning HJ, van der Aalst CM, de Jong PA, et al. Reduced lung‑cancer mortality with volume CT screening in a randomized trial. N Engl J Med. 2020;382(6):503–513. DOI: 10.1056/NEJMoa1911793.
- Desimpel F, Luyten J, Camberlin C, et al. Lung cancer screening in a high‑risk population [Internet]. Available from:
www.kce.fgov.be . DOI: 10.57598/R379CS. - Sands J, Tammemägi MC, Couraud S, et al. Lung screening benefits and challenges: A review of the data and outline for implementation. J Thorac Oncol. 2021;16(1):37–53. DOI: 10.1016/j.jtho.2020.10.127.
- Joseph AM, Rothman AJ, Almirall D, et al. Lung cancer screening and smoking cessation clinical trials SCALE (smoking cessation within the context of lung cancer screening) collaboration. Am J Respir Crit Care Med. 2018;197(2):172–182. DOI: 10.1164/rccm.201705-0909CI.
- Van Meerbeeck JP, O’dowd E, Ward B, Van Schil P, Snoeckx A. Lung cancer screening: New perspective and challenges in Europe. Cancers (Basel). 2022;14(9):2343. DOI: 10.3390/cancers14092343.
- Council of the EU. Council updates its recommendation to screen for cancer. 2022 [cited 2024 February 23]. Available from:
https://www.consilium.europa.eu/en/press/press-releases/2022/12/09/council-updates-its-recommendation-to-screen-for-cancer/ .